
Sysmex Corporation – OTC:SSMXY
Sysmex stock price today
Sysmex stock price monthly change
Sysmex stock price quarterly change
Sysmex stock price yearly change
Sysmex key metrics
Market Cap | 14.02B |
Enterprise value | 1.79T |
P/E | 34.93 |
EV/Sales | 3.74 |
EV/EBITDA | 15.29 |
Price/Sales | 3.80 |
Price/Book | 4.05 |
PEG ratio | 0.01 |
EPS | 145.57 |
Revenue | 441.77B |
EBITDA | 113.02B |
Income | 47.62B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 10.89% |
Oper. margin | 16.92% |
Gross margin | 52.74% |
EBIT margin | 16.92% |
EBITDA margin | 25.58% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSysmex stock price history
Sysmex stock forecast
Sysmex financial statements
Dec 2021 | 90.14B | 10.65B | 11.82% |
---|---|---|---|
Mar 2022 | 104.87B | 11.19B | 10.67% |
Mar 2023 | 111.75B | 10.59B | 9.48% |
Mar 2024 | 134.98B | 15.17B | 11.24% |
Sep 2025 | 123.63B | 0 | |
---|---|---|---|
Oct 2025 | 123.63B | 0 | |
Dec 2025 | 119.39B | 0 | |
Mar 2026 | 136.36B | 0 |
Analysts Price target
Financials & Ratios estimates
Payout ratio | 33.66% |
---|
2020 | 0.94% |
---|---|
2021 | 0.6% |
2022 | 0.83% |
2023 | 0.91% |
2024 | 1.06% |
Sep 2022 | 511230000000 | 130.83B | 25.59% |
---|---|---|---|
Dec 2022 | 501435000000 | 127.35B | 25.4% |
Mar 2023 | 531074000000 | 142.71B | 26.87% |
Mar 2024 | 618920000000 | 186.02B | 30.06% |
Dec 2021 | 13.71B | -11.41B | -8.21B |
---|---|---|---|
Mar 2022 | 7.79B | -8.37B | -1.67B |
Mar 2023 | 28.95B | -13.24B | -1.88B |
Mar 2024 | 25.03B | -13.10B | 1.69B |
Sysmex alternative data
Sep 2023 | 9,500 |
---|---|
Oct 2023 | 9,500 |
Nov 2023 | 9,500 |
Dec 2023 | 9,500 |
Jan 2024 | 9,500 |
Feb 2024 | 9,500 |
Mar 2024 | 9,500 |
Apr 2024 | 9,500 |
May 2024 | 9,500 |
Jun 2024 | 9,500 |
Jul 2024 | 10,042 |
Sysmex other data
-
What's the price of Sysmex stock today?
One share of Sysmex stock can currently be purchased for approximately $13.37.
-
When is Sysmex's next earnings date?
Unfortunately, Sysmex's (SSMXY) next earnings date is currently unknown.
-
Does Sysmex pay dividends?
Yes, Sysmex pays dividends and its trailing 12-month yield is 1.02% with 34% payout ratio. The last Sysmex stock dividend of undefined was paid on 6 Sep 2025.
-
How much money does Sysmex make?
Sysmex has a market capitalization of 14.02B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12.43% to 461.51B US dollars.
-
What is Sysmex's stock symbol?
Sysmex Corporation is traded on the OTC under the ticker symbol "SSMXY".
-
What is Sysmex's primary industry?
Company operates in the Healthcare sector and Medical Instruments & Supplies industry.
-
How do i buy shares of Sysmex?
Shares of Sysmex can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Sysmex have?
As Jul 2024, Sysmex employs 10,042 workers, which is 6% more then previous month and 6% more then previous quarter.
-
When Sysmex went public?
Sysmex Corporation is publicly traded company for more then 6 years since IPO on 30 Nov 2018.
-
What is Sysmex's official website?
The official website for Sysmex is sysmex.co.jp.
-
How can i contact Sysmex?
Sysmex can be reached via phone at +81 78 265 0500.
Sysmex company profile:

Sysmex Corporation
sysmex.co.jpOTC
8,771
Medical Instruments & Supplies
Healthcare
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
Kobe, 651-0073
:
ISIN: US87184P1093
CUSIP: 87184P109